5.5281
Oncology Institute Inc stock is traded at $5.5281, with a volume of 1.10M.
It is up +4.75% in the last 24 hours and up +13.57% over the past month.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
See More
Previous Close:
$5.28
Open:
$5.45
24h Volume:
1.10M
Relative Volume:
0.64
Market Cap:
$552.91M
Revenue:
$545.76M
Net Income/Loss:
$-36.28M
P/E Ratio:
-14.73
EPS:
-0.3754
Net Cash Flow:
$-25.73M
1W Performance:
-1.24%
1M Performance:
+13.57%
6M Performance:
+33.92%
1Y Performance:
+119.48%
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TOI
Oncology Institute Inc
|
5.53 | 542.91M | 545.76M | -36.28M | -25.73M | -0.3754 |
|
HCA
Hca Healthcare Inc
|
415.44 | 86.49B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
206.28 | 16.11B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
236.20 | 14.28B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.14B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
106.34 | 10.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Enterprise value to EBITDA forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
Price to sales forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Microcap Value Benchmark Index - marketscreener.com
The Oncology Institute, Inc.(NasdaqCM: TOI) added to Russell 2000 Value Benchmark - marketscreener.com
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo Finance Singapore
The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
The Sarah Cannon Cancer Institute from HCA Healthcare Inc.quiet specialization in community oncol - Ad-hoc-news.de
Oncology Institute Inc (TOIIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Oncology Institute Inc (TOI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oncology Institute Inc (TOI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
Oncology institute ten percent owner Jorey Chernett buys $90k in stock - Investing.com
Form 4 Oncology Institute Inc For: 24 June By Investing.com - Investing.com Australia
Oncology Institute (TOI) major holder Jorey Chernett buys 18,000 shares - Stock Titan
How much upside is left in the Oncology Institute (TOI)? Wall Street analysts think 38.07% - MSN
Oncology Institute Shareholders Approve Directors and Annual Say-on-Pay - The Globe and Mail
TOI News | ONCOLOGY INSTITUTE INC/THE (NASDAQ:TOI) - ChartMill
Oncology Institute (TOI) 2026 meeting backs board, auditor and annual say-on-pay - Stock Titan
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion - GlobeNewswire
Oncology Institute Inc (TOIIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Oncology Institute Inc (TOI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oncology Institute Inc (TOI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oncology Institute Inc (TOI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oncology Institute Inc (TOIIW) Institutional Confidence - TradingKey
Oncology Institute Inc (TOIIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oncology Institute Inc (TOIIW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oncology Institute Inc (TOIIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Needham raises Oncology Institute stock price target to $7 on growth outlook - Investing.com UK
TOI Maintained by Needham -- Price Target Raised to $7.00 - GuruFocus
Oncology Institute Inc (TOIIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oncology Institute Inc (TOIIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oncology Institute Inc (TOIIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oncology Institute Inc (TOI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oncology Institute Inc (TOI) Institutional Confidence - TradingKey
Oncology Institute Inc. (TOI) Faces Selling Pressure, Drops 5.37% to $5.03Price Action Signals - dars.gov.et
The Oncology Institute Inc. Warrant (TOIIW) Holds Steady at $0.05 Amid Low VolatilityOverbought Signal Alerts - newsline.com
The Oncology Institute Inc. (TOI) Gains 3.5% as Stock Tests Key Resistance at $5.58Dollar Neutral Pair - newsline.com
Insider Sell Alert: Yale Podnos Sells Shares of The Oncology Ins - GuruFocus
Oncology institute CMO Yale Podnos sells $126,093 in stock By Investing.com - Investing.com Nigeria
Oncology institute CMO Yale Podnos sells $126,093 in stock - Investing.com UK
[Form 4] Oncology Institute, Inc. Insider Trading Activity - Stock Titan
Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday - Sahm
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07% - sharewise.com
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oncology Institute Inc Stock (TOI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Podnos Yale | Chief Medical Officer |
Jun 08 '26 |
Sale |
5.38 |
23,451 |
126,094 |
259,527 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):